Nations Financial Group Inc. IA ADV purchased a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 1,041 shares of the biotechnology company’s stock, valued at approximately $229,000. Other large investors also recently […]
Shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report) dropped 8.9% during mid-day trading on Tuesday . The company traded as low as $3.02 and last traded at $3.08. Approximately 835,770 shares changed hands during trading, a decline of 62% from the average daily volume of 2,217,036 shares. The stock had previously closed at […]
HC Wainwright reiterated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Thursday, Benzinga reports. HC Wainwright currently has a $54.00 target price on the stock. A number of other research firms have also issued reports on RNAC. Needham & Company LLC reaffirmed a buy rating and […]
Bernzott Capital Advisors trimmed its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 27.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 124,979 shares of the biopharmaceutical company’s stock after selling 46,829 shares during the quarter. Bernzott Capital Advisors’ holdings in Halozyme Therapeutics were worth $4,619,000 at the end of […]
Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) dropped 4.7% during trading on Friday after Guggenheim lowered their price target on the stock from $16.00 to $14.00. Guggenheim currently has a buy rating on the stock. Tango Therapeutics traded as low as $6.68 and last traded at $6.76. Approximately 85,654 shares changed hands […]